Home / Recalls / Lannett Company Inc. / D-0642-2025

D-0642-2025 Class II Ongoing

Recalled by Lannett Company Inc. — Seymour, IN

Recall Details

Product Type
Drugs
Report Date
September 17, 2025
Initiation Date
August 19, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,848 bottles

Product Description

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100 Tablets per bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-0762-37.

Reason for Recall

Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.

Distribution Pattern

OH

Code Information

Lot#: 25283185A. Expiry: 02/28/2027

Other recalls by Lannett Company Inc.

  • D-0096-2026 Class II — Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, (October 10, 2025)
  • D-0599-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distrib (August 11, 2025)
  • D-0112-2025 Class II — Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, D (October 25, 2024)
  • D-0161-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 (November 9, 2022)
  • D-0160-2023 Class III — Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 (November 9, 2022)
  • D-0558-2022 Class II — Diazepam Oral Solution (Concentrate), 25 mg per 5 mL (5 mg/mL), 30 mL BOTTLE and (February 9, 2022)
  • D-1508-2020 Class II — Prednisone Tablets, USP 2.5 mg, 100 tablets, Rx only, Distributed by: Lannett C (August 10, 2020)
  • D-0630-2020 Class I — Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Dist (December 6, 2019)
  • D-0309-2020 Class II — Lannett Ranitidine Syrup (Ranitidine Oral Solution, USP), 15mg/mL Rx Only Distr (October 28, 2019)
  • D-0996-2019 Class III — Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, D (February 21, 2019)